You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 53 No. 6, June 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Psychiatric Symptoms Do Not Correlate With Cognitive Decline, Motor Symptoms, or CAG Repeat Length in Huntington's Disease

Boris Zappacosta, MD; Daniela Monza, MD; Cesare Meoni, PhD; Laura Austoni, PhD; Paola Soliveri, MD; Cinzia Gellera, PhD; Roberto Alberti, MD; Mario Mantero, MD; Gaetano Penati, MD; Tommaso Caraceni, MD; Floriano Girotti, MD

Arch Neurol. 1996;53(6):493-497.


Abstract

Objectives
To investigate the hypothesis that psychiatric disturbances in Huntington's disease are related to degree of cognitive or motor compromise and to determine correlations between CAG repeat length within the gene for Huntington's disease and disease severity.

Design
Consecutive series of patients with Huntington's disease.

Setting
Neurological specialty hospital.

Patients
Seventeen men and 12 women from 24 families.

Main Outcome Measures
The Hamilton Psychiatric and Anxiety Rating Scales and Brief Psychiatric Rating Scale were used to assess psychiatric disturbances; Folstein's Quantified Neurological Examination to evaluate motor status; and the Mini-Mental State Examination, Raven Progressive Matrices), Phonemic Verbal Fluency Test, Short Tale Test, Visual Search Test, and Benton's Visual Orientation Line Test to evaluate cognitive function. The length of the CAG repeat sequence in the Huntington's gene was determined by quantitative polymerase chain reaction.

Results
Cognitive test scores correlated significantly with each other; of these, results of the Visual Search and Short Tale tests correlated significantly with the Folstein's Quantified Neurological Examination score (P=.05 and P=.03, respectively). Results of the Folstein's Quantified Neurological Examination also correlated with the illness duration and the length of the CAG repeat. Although psychiatric scores correlated significantly among themselves (P<.01), neither cognitive compromise, motor deterioration, nor CAG length were related to the extent of psychiatric compromise. Patients who were depressed when they were examined tended to have a history of psychiatric disorders.

Conclusions
The lack of correlation between disease severity and psychiatric disturbances indicates that psychiatric disorders progress nonlinearly, possibly because of differential degeneration of the striatal-cortical circuits; the possibility that psychiatric disorders are prevalent in certain families with a member who has Huntington's disease is being further investigated. The lack of correlation between CAG length and cognitive and psychiatric variables needs further investigation.



Author Affiliations

From the Istituto Nazionale Neurologico "C. Besta," Milan, Italy (Drs Zappacosta, Monza, Meoni, Austoni, Soliveri, Gellera, Caraceni, and Girotti), and the Istituto di Clinica Psichiatrica, University of Milan (Drs Alberti, Mantero, and Penati).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin
Pouladi et al.
Brain 2009;132:919-932.
ABSTRACT | FULL TEXT  

Psychopathology in Verified Huntington's Disease Gene Carriers
van Duijn et al.
J. Neuropsychiatry Clin. Neurosi. 2007;19:441-448.
ABSTRACT | FULL TEXT  

Longitudinal Evaluation of "Presymptomatic" Carriers of Huntington's Disease
Witjes-Ane et al.
J. Neuropsychiatry Clin. Neurosi. 2007;19:310-317.
ABSTRACT | FULL TEXT  

Striosomes and mood dysfunction in Huntington's disease
Tippett et al.
Brain 2007;130:206-221.
ABSTRACT | FULL TEXT  

Depression and Stages of Huntington's Disease
Paulsen et al.
J. Neuropsychiatry Clin. Neurosi. 2005;17:496-502.
ABSTRACT | FULL TEXT  

Behavior in Huntington's Disease: Dissociating Cognition-Based and Mood-Based Changes
Thompson et al.
J. Neuropsychiatry Clin. Neurosi. 2002;14:37-43.
ABSTRACT | FULL TEXT  

Familial Aggregation of Psychotic Symptoms in Huntington's Disease
Tsuang et al.
Am. J. Psychiatry 2000;157:1955-1959.
ABSTRACT | FULL TEXT  

Genetic polymorphisms adjacent to the CAG repeat influence clinical features at onset in Huntington's disease
Vuillaume et al.
J. Neurol. Neurosurg. Psychiatry 1998;64:758-762.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.